DUCOMMUN INC /DE/
DUCOMMUN INC /DE/ Q3 FY2025 earnings call
November 8, 2025 · fiscal period ended 2025-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-11-08
Management highlights
Management Statement and Operational Highlights
- VISION 2027 Strategy: Executing the strategy to increase engineered products and aftermarket content (23% in 2025, up from 15% in 2022), consolidating rooftops, running a focused acquisition program, driving value-added pricing, and expanding content on key commercial aerospace platforms.
- Financial Results: Q3 2025 revenue reached $212.6 million (6% growth year-over-year). Defense business grew 13%, offsetting a 10% decline in commercial aerospace. Record bookings of $338 million in Q3 (book-to-bill 1.6x), with remaining performance obligations ($1.03 billion) at a new record.
- Defense Programs: Apache tail rotor blade in production in Coxsackie, New York; missile case in production in Guaymas, Mexico; Tomahawk set for full production in 2026. Growth with BAE Systems (over $21 million, up 39% year-to-date).
- Litigation Settlement: Entered a binding settlement term sheet to resolve Guaymas Fire litigation, paying $150 million with $56 million funded by insurance carriers, and settling ancillary subrogation claims for $1.35 million.
Segment performance
Segment Performance
- Structural Systems: Revenue in Q3 2025 was $89 million (vs $86 million in 2024). Operating income was $11.9 million (13.3% of revenue) vs $8.3 million (9.6% of revenue) in the prior year. Excluding adjustments, the segment margin was 16% in Q3 2025 vs 14.7% in Q3 2024.
- Electronic Systems: Revenue in Q3 2025 was $123.1 million (vs $115.4 million in 2024). Operating income was $21.1 million (17.1% of revenue) vs $18.9 million (16.4% of revenue) in the prior year. Excluding adjustments, the segment margin was 17.5% in Q3 2025 vs 16.8% in Q3 2024.
- Commercial Aerospace: Declined 10% in Q3 2025 to $77 million, driven by lower rates on regional and business jets.
- Defense (Military and Space): Revenue was $126 million in 2025 vs $111 million in 2024, up 13% due to growth in missile programs, military rotorcraft, and radar systems.
Guidance
Guidance
- Full-year 2025 revenue expected to grow mid-single-digit, with Q4 projected to have low double-digit growth.
- Reaffirms VISION 2027 goal of 18% adjusted EBITDA by 2027, currently at 16.2% in Q3 2025. Confident in defense growth, with commercial aerospace outlook improving after destocking.
- Book-to-bill of 1.6x in Q3, with Q4 looking strong across all segments.
Risks
Risks
- Cyclicality of end-use markets, U.S. government defense spending, customer delays in product launch/certification and order timing.
- Financing challenges, legal/regulatory risks including Guaymas Fire litigation, and potential losses from third-party supplier claims.
- Competition, economic and geopolitical developments (supply chain issues, tariffs, labor disruptions), intellectual property protection, pandemics, disasters, and cybersecurity attacks.
Q&A highlights
Question and Answer
Q: Strong bookings in commercial aerospace, can you provide more detail?
A: MAX build rates, shipments mid-25 to high-28, growth in Airbus and Boeing bookings. We're seeing mid-20s to high-20s in shipments, with growth in bookings across Boeing and Airbus, including work on Airbus nacelles.
Q: Difference between RPO and backlog?
A: RPO is remaining performance obligations (unconstrained revenue yet to be recognized), while backlog is linked to shipments, includes LTA forecasts and is constrained to a 2-year window.
Q: Margins expansion cadence?
A: Facility consolidation savings, strategic pricing, and engineered products mix driving margins. Savings from plant consolidation and strategic pricing initiatives are key drivers.
Q: M&A capacity post-litigation?
A: Revolver available, net leverage expected to be low 2s after litigation payment, with discussions to increase facility size for M&A to support acquisition strategy.
Q: Golden Dome impact?
A: Well-positioned in missile and radar franchises, involved in relevant programs but details pending. We're part of key missile platforms and radar programs aligned with defense priorities.
Q: 2026 top-line growth?
A: Guidance to be provided early 2026. Defense growth strong, but commercial aerospace destocking impact expected to continue in first half of 2026.
Q: 4Q low double-digit growth with destocking?
A: Continued strength in defense business. Defense growth is a key driver for Q4's low double-digit growth.
Q: Cash payment for litigation?
A: Net payment outflow of $95 million, with $56 million funded by insurance carriers.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 8, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.